QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
NASDAQ:QTRX

Quanterix (QTRX) Stock Forecast, Price & News

$17.90
-0.89 (-4.74%)
(As of 05/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$17.79
$19.02
50-Day Range
$15.42
$30.65
52-Week Range
$14.86
$69.22
Volume
223,831 shs
Average Volume
320,430 shs
Market Capitalization
$660.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.59
30 days | 90 days | 365 days | Advanced Chart
Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

Quanterix logo

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Headlines

Quanterix reports Q1 results
Quanterix (NASDAQ:QTRX) Reaches New 12-Month Low at $21.13
See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:QTRX
Fax
N/A
Employees
460
Year Founded
N/A

Sales & Book Value

Annual Sales
$110.56 million
Book Value
$12.03 per share

Profitability

Net Income
$-57.69 million
Pretax Margin
-52.21%

Debt

Price-To-Earnings

Miscellaneous

Free Float
31,226,000
Market Cap
$660.49 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/01/2022
Today
5/16/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.28 out of 5 stars

Medical Sector

270th out of 1,423 stocks

Analytical Instruments Industry

10th out of 32 stocks

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -













Quanterix (NASDAQ:QTRX) Frequently Asked Questions

Is Quanterix a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Quanterix stock.
View analyst ratings for Quanterix
or view top-rated stocks.

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Quanterix
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) issued its quarterly earnings data on Tuesday, March, 1st. The company reported ($0.55) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.66) by $0.11. The business earned $29.31 million during the quarter, compared to analyst estimates of $29 million. Quanterix had a negative net margin of 58.23% and a negative trailing twelve-month return on equity of 14.47%. During the same quarter in the prior year, the firm posted ($0.31) EPS.
View Quanterix's earnings history
.

What price target have analysts set for QTRX?

3 analysts have issued 1 year price targets for Quanterix's shares. Their forecasts range from $35.00 to $60.00. On average, they expect Quanterix's stock price to reach $44.20 in the next year. This suggests a possible upside of 146.9% from the stock's current price.
View analysts' price targets for Quanterix
or view top-rated stocks among Wall Street analysts.

Who are Quanterix's key executives?
Quanterix's management team includes the following people:
  • Mr. E. Kevin Hrusovsky, Exec. Chairman (Age 60, Pay $1.33M)
  • Dr. David R. Walt Ph.D., Co-Founder, Chairman of Scientific Advisory Board & Independent Director (Age 69, Pay $41k)
  • Dr. Masoud Toloue Ph.D., Pres, CEO & Director (Age 41)
  • Mr. Michael A. Doyle, CFO & Treasurer (Age 66)
  • Mr. Bruce J. Bal, VP of Operations, Service & Quality (Age 63)
  • Dr. David C. Duffy Ph.D., Sr. VP of R&D and CTO (Age 51)
  • Mr. John J. Fry, Gen. Counsel & Corp. Sec. (Age 61) (LinkedIn Profile)
  • David Panzerella, VP of Sales
  • Dr. Mark T. Roskey Ph.D., Sr. VP of Strategic Partnerships (Age 62)
  • Dr. Dawn R. Mattoon Ph.D., Sr. VP of Diagnostics (Age 49)
What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix CEO Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among Quanterix's employees.

What other stocks do shareholders of Quanterix own?
When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.61%), Vanguard Group Inc. (4.75%), Frontier Capital Management Co. LLC (3.87%), Granahan Investment Management LLC (3.12%), Invesco Ltd. (2.97%) and Bank of New York Mellon Corp (2.26%). Company insiders that own Quanterix stock include Amol Chaubal, David C Duffy, David C Duffy, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, John J Fry, Marijn E Dekkers, Marijn E Dekkers, Mark T Roskey, Mark T Roskey and Martin D Madaus.
View institutional ownership trends for Quanterix
.

Which institutional investors are selling Quanterix stock?

QTRX stock was sold by a variety of institutional investors in the last quarter, including Bellevue Group AG, Lord Abbett & CO. LLC, Bank of New York Mellon Corp, Victory Capital Management Inc., CWM LLC, D.A. Davidson & CO., Vanguard Group Inc., and BlackRock Inc.. Company insiders that have sold Quanterix company stock in the last year include David C Duffy, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, Marijn E Dekkers, and Mark T Roskey.
View insider buying and selling activity for Quanterix
or view top insider-selling stocks.

Which institutional investors are buying Quanterix stock?

QTRX stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Granahan Investment Management LLC, Frontier Capital Management Co. LLC, Tikvah Management LLC, Sector Gamma AS, Dimensional Fund Advisors LP, Candriam Luxembourg S.C.A., and Monarch Partners Asset Management LLC.
View insider buying and selling activity for Quanterix
or or view top insider-buying stocks.

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $17.90.

How much money does Quanterix make?

Quanterix has a market capitalization of $660.49 million and generates $110.56 million in revenue each year. The company earns $-57.69 million in net income (profit) each year or ($1.800010) on an earnings per share basis.

How many employees does Quanterix have?

Quanterix employs 460 workers across the globe.

What is Quanterix's official website?

The official website for Quanterix is www.quanterix.com.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at (617) 301-9400 or via email at [email protected].

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.